115 related articles for article (PubMed ID: 38230588)
1. Elevated tissue expression of RANKL and RANK is associated with poorer survival rates in pancreatic cancer patients.
Ortega MA; Jiménez-Álvarez L; Fraile-Martinez O; Garcia-Montero C; De León-Oliva D; Toledo-Lobo MDV; Palacios E; Granado P; Esteban A; Guijarro LG; Pekarek L; Asúnsolo Á; López-González L; Bujan J; García-Honduvilla N; Álvarez-Mon M; Saez MA; Díaz-Pedrero R
Histol Histopathol; 2023 Dec; ():18700. PubMed ID: 38230588
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer.
Ortega MA; Jiménez-Álvarez L; Fraile-Martinez O; Garcia-Montero C; Guijarro LG; Pekarek L; Barrena-Blázquez S; Asúnsolo Á; López-González L; Toledo-Lobo MDV; Álvarez-Mon M; Saez MA; Gutiérrez-Calvo A; Díaz-Pedrero R
Curr Issues Mol Biol; 2024 Apr; 46(5):3839-3865. PubMed ID: 38785507
[TBL] [Abstract][Full Text] [Related]
3. Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.
Park HS; Lee A; Chae BJ; Bae JS; Song BJ; Jung SS
J Surg Oncol; 2014 Dec; 110(7):807-12. PubMed ID: 25111682
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
[TBL] [Abstract][Full Text] [Related]
5. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.
Azim HA; Peccatori FA; Brohée S; Branstetter D; Loi S; Viale G; Piccart M; Dougall WC; Pruneri G; Sotiriou C
Breast Cancer Res; 2015 Feb; 17():24. PubMed ID: 25849336
[TBL] [Abstract][Full Text] [Related]
6. Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
Reyes ME; Fujii T; Branstetter D; Krishnamurthy S; Masuda H; Wang X; Reuben JM; Woodward WA; Edwards BJ; Hortobagyi GN; Tripathy D; Dougall WC; Eckhardt BL; Ueno NT
Breast Cancer Res Treat; 2017 Jul; 164(1):57-67. PubMed ID: 28417335
[TBL] [Abstract][Full Text] [Related]
7. RANK and RANKL Expression in Tumors of Patients with Early Breast Cancer.
Behrens A; Wurmthaler L; Heindl F; Gass P; Häberle L; Volz B; Hack CC; Emons J; Erber R; Hartmann A; Beckmann MW; Ruebner M; Dougall WC; Press MF; Fasching PA; Huebner H
Geburtshilfe Frauenheilkd; 2024 Jan; 84(1):77-85. PubMed ID: 38178900
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological significance of ISYNA1 expression in pancreatic ductal adenocarcinoma].
Zhou L; Sheng WW; Shi XY; Zhou JP; Dong M
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):206-211. PubMed ID: 30861650
[No Abstract] [Full Text] [Related]
9. Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasis.
Zhang L; Teng Y; Zhang Y; Liu J; Xu L; Qu J; Hou K; Yang X; Liu Y; Qu X
J Clin Pathol; 2012 Jan; 65(1):36-40. PubMed ID: 22049226
[TBL] [Abstract][Full Text] [Related]
10. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.
Chen G; Sircar K; Aprikian A; Potti A; Goltzman D; Rabbani SA
Cancer; 2006 Jul; 107(2):289-98. PubMed ID: 16752412
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data.
Chua HH; Tuan Sharif SE; Wan Ismail WFN; Zawawi MSF; Abdullah S
Asian Pac J Cancer Prev; 2021 Mar; 22(3):741-747. PubMed ID: 33773537
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma.
Chung HW; Lim JB
J Transl Med; 2014 Apr; 12():102. PubMed ID: 24745825
[TBL] [Abstract][Full Text] [Related]
13. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
14. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
15. Expression Profiling of Receptor-Activator of Nuclear Factor-Kappa B Ligand in Soft Tissue Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Oike N; Sasaki T; Hatano H; Ohashi R; Umezu H; Ajioka Y; Endo N
Tohoku J Exp Med; 2019 Jun; 248(2):87-97. PubMed ID: 31189751
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma.
Liu WJ; Zhou L; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP
Chin Med J (Engl); 2018 Dec; 131(24):2947-2952. PubMed ID: 30539907
[TBL] [Abstract][Full Text] [Related]
17. Potential role of the OPG/RANK/RANKL axis in prostate cancer invasion and bone metastasis.
Li X; Liu Y; Wu B; Dong Z; Wang Y; Lu J; Shi P; Bai W; Wang Z
Oncol Rep; 2014 Dec; 32(6):2605-11. PubMed ID: 25333856
[TBL] [Abstract][Full Text] [Related]
18. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
19. Predictive and Prognostic Value of SUOX Expression in Pancreatic Ductal Adenocarcinoma.
Naito Y; Akiba J; Kinjo Y; Sadashima E; Ogata T; Yano Y; Tanigawa M; Nakayama M; Kawahara A; Okabe Y; Sakai H; Hisaka T; Akagi Y; Yano H
Anticancer Res; 2022 Aug; 42(8):4145-4151. PubMed ID: 35896256
[TBL] [Abstract][Full Text] [Related]
20. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
